Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer

類似資料

• The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
  著者:: Chang, Shih-Chieh, 等
  出版事項: (2011)
• Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
  著者:: Zhang, Yan, 等
  出版事項: (2017)
• Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
  著者:: Banno, Eri, 等
  出版事項: (2016)
• Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
  著者:: Asami, Kazuhiro, 等
  出版事項: (2014)
• Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer: To Test or Not to Test?
  著者:: Gazdar, Adi F.
  出版事項: (2011)